Monoclonal antibodies (mAbs) are highly specific, laboratory-produced antibodies designed to target a single specific epitope or binding site on an antigen. Unlike polyclonal antibodies, which are a ...

Monoclonal antibodies target specific disease molecules. They can help treat cancer, autoimmune disorders, and infectious diseases. Discover what you should know about this therapy. Monoclonal ...

Monoclonal antibodies are widely used to treat diseases ranging from cancer to autoimmune disorders. The safety and efficacy ...

Monoclonal antibodies are a type of biologic medication that can treat moderate to severe inflammatory bowel disease (IBD) by targeting specific inflammatory processes in your body. Your doctor might ...

Please provide your email address to receive an email when new articles are posted on . More than half of survey respondents being treated with monoclonal antibodies experienced a “wearing-off” effect ...

In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from ...

In this video, Jeremy Faust, MD, editor-in-chief of MedPage Today, looks at the rise and fall of monoclonal antibodies for COVID-19, and discusses the population most affected by the FDA's reversal of ...

Monoclonal antibodies (mAbs) have revolutionized cancer therapy due to their ability to specifically target tumor cells while sparing healthy ones. These biologics have become indispensable in ...

From 31 centers, 166 patients were entered. Of this intent-to-treat group, 48% responded. With a median follow-up duration of 11.8 months, the projected median time to progression for responders is 13 ...